Should You Buy Alaunos Therapeutics Inc (TCRT) Stock on Friday?
Alaunos Therapeutics Analyst Ratings
H.C. Wainwright Downgrades Alaunos Therapeutics (TCRT) to a Hold
Alaunos Therapeutics Analyst Ratings
HC Wainwright & Co. Upgrades Alaunos Therapeutics to Buy, Announces $1.5 Price Target
Alaunos Therapeutics (TCRT) Was Upgraded to a Buy Rating at H.C. Wainwright
Wells Fargo Assumes Alaunos Therapeutics at Overweight, Announces Price Target of $3
Wells Fargo Keeps Their Buy Rating on Alaunos Therapeutics (TCRT)
Analysts Offer Insights on Healthcare Companies: Durect (DRRX), Alaunos Therapeutics (TCRT) and Marinus (MRNS)
H.C. Wainwright Sticks to Their Hold Rating for Alaunos Therapeutics (TCRT)
Alaunos Therapeutics Analyst Ratings
Wells Fargo Assumes Alaunos Therapeutics at Overweight, Announces Price Target of $3
H.C. Wainwright Remains a Hold on Alaunos Therapeutics (TCRT)
Cantor Fitzgerald Assumes Alaunos Therapeutics at Overweight with $3 Price Target
Alaunos Therapeutics Price Target Announced at $3.00/Share by Cantor Fitzgerald
Alaunos Therapeutics analyst ratings
Cantor Fitzgerald Assumes Alaunos Therapeutics at Overweight, Announces Price Target of $3
No Data
No Data